ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

VALFIX Medical Inc. Announces the Appointment of Former Abbott Ventures DVP, Evan Norton as New Independent Board Member

By: PRLog

DOVER, Del. - Feb. 1, 2022 - PRLog -- VALFIX Medical Inc. announced today the appointment of former Abbott Venture Divisional Vice President (DVP), Mr. Evan Norton as the company's independent board member making him the company's fifth board of directors' member.

"We are delighted to have Evan on VALFIX's board of directors. His business and market experience and talents in MedTech innovation are extremely valuable assets as VALFIX continues to grow and we continue to advance our technology," commented Eli Bar, CEO and Chairman of the board. "Together, with Evan and the rest of our board, we look forward to our continued success in driving the VALFIX technology toward achieving our goals."

Mr. Norton spent a decade with Abbott leading the corporate venture arm, Abbott Ventures. During this time, Mr. Norton managed the company's minority equity investments, structured transactions, and private company acquisitions on behalf of both Abbott's business units as well as developing entry strategies in white space markets.

"I am delighted to join VALFIX's board of directors. When I was approached by Eli Bar with this opportunity and, after learning more about the VALFIX team and technology potential, I knew it was a company I wanted to be involved with," stated Evan. "I am confident in Eli's leadership, VALFIX's success to date in achieving their milestones, and the ongoing potential of the company.

Mr. Norton has an MBA from Northwestern's Kellogg School of Management where he serves as an adjunct lecturer teaching "Medical Products Commercialization and Funding."

About VALFIX Medical:

VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative technology offers a viable alternative to open heart surgery. To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com

Media Contact:

Devra Igra
+972 73 374 4805
devra.igra@valfixmed.com

Contact
Elad Yaacoby
***@valfixmed.com

Photos: (Click photo to enlarge)

VALFIX Medical Logo

Read Full Story - VALFIX Medical Inc. Announces the Appointment of Former Abbott Ventures DVP, Evan Norton as New Independent Board Member | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.